[SCHEDULE 13G/A] Aimei Health Technology Co., Ltd Unit SEC Filing

Rhea-AI Filing Summary

Mizuho Financial Group reports beneficial ownership of 550,600 common shares of Aimei Health Technology, representing 9.0% of the outstanding class. The filing states Mizuho has sole voting and dispositive power over these shares and that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

The filing is made by the parent holding company and discloses that related entities (Mizuho Bank, Mizuho Americas LLC) may be deemed indirect beneficial owners through a wholly owned broker-dealer subsidiary.

Insights

Financial Analyst

TL;DR: Mizuho holds a material, passive 9.0% stake (550,600 shares) in Aimei Health, disclosed as held in the ordinary course of business.

The filing explicitly reports 550,600 shares (9.0%) with sole voting and dispositive power. Because the filer affirms the stake was not acquired to influence control, this is a passive institutional holding disclosure rather than an activist move. The disclosure clarifies potential indirect ownership via related Mizuho entities and a broker-dealer subsidiary, which is material for ownership transparency.

Corporate Governance Expert

TL;DR: A 9.0% holding by a major financial group is material to governance transparency but is presented as non-control and passive.

The statement certifies the position was acquired and is held in the ordinary course and expressly not for changing or influencing control. For governance purposes, a single institutional holder at 9.0% merits disclosure and monitoring by other shareholders, yet the filer’s explicit certification signals no immediate intent to pursue board or control actions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Aimei Health Technology Co., Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

G01341109

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G01341109

1

Names of Reporting Persons

Mizuho Financial Group, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 550,600.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 550,600.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

550,600.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.0 %

12

Type of Reporting Person (See Instructions)

FI

Comment for Type of Reporting Person: Mizuho Financial Group, Inc., Mizuho Bank, Ltd. and Mizuho Americas LLC may be deemed to be indirect beneficial owners of said equity securities directly held by Mizuho Securities USA LLC which is their wholly-owned subsidiary.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aimei Health Technology Co., Ltd.
(b)	Address of issuer's principal executive offices: 10 East 53rd Street Suite 3001 New York, NY, 10022
Item 2.
(a)	Name of person filing: Mizuho Financial Group, Inc.
(b)	Address or principal business office or, if none, residence: 1-5-5, Otemachi, Chiyoda-ku, Tokyo, 100-8176, Japan
(c)	Citizenship: Japan
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: G01341109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Parent Holding Company
Item 4.	Ownership
(a)	Amount beneficially owned: 550,600
(b)	Percent of class: 9.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 550,600
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 550,600
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit A
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Parent Holding Company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mizuho Financial Group, Inc.

Signature:	/s/ Takahiro Katsura
Name/Title:	Takahiro Katsura, Managing Director, Global Corporate Function Coordination Department
Date:	08/13/2025

FAQ

What stake does Mizuho Financial Group report in Aimei Health Technology (AFJKU)?

Mizuho reports beneficial ownership of 550,600 common shares, equal to 9.0% of the class.

Does Mizuho have voting or dispositive power over the AFJKU shares?

Yes. The filing states Mizuho has sole voting power and sole dispositive power for all 550,600 shares.

Is Mizuho claiming the stake is intended to influence control of AFJKU?

No. The filing certifies the shares were not acquired and are not held for the purpose of changing or influencing control.

Are any Mizuho subsidiaries identified as indirect owners of the AFJKU shares?

Yes. The filing notes Mizuho Bank, Ltd. and Mizuho Americas LLC may be deemed indirect beneficial owners through Mizuho Securities USA LLC, their wholly owned subsidiary.

What type of Schedule filing is this for AFJKU?

This is a Schedule 13G/A disclosure by a parent holding company reporting beneficial ownership.